Skip to main content
Move the World.
Can The Common Cold Help Battle COVID-19?

Lead Image © filins / Adobe Stock

A team of researchers, perched on the Pacific at San Diego's La Jolla Institute for Immunology, have demonstrated that people who have been infected by one of the coronaviruses that cause the common cold may carry some protections against their brutal relative, SARS-CoV-2.

Numerous labs have found that blood samples from people never exposed to SARS-CoV-2 — the culprit behind COVID-19 — have immune cells that may help stave off the virus.

Spilling The T (Cells)

The immune system is notoriously complex, and the fact that the body's immune response to the novel coronavirus is so unusual makes it even more so. In addition to the hunter-killer cells that seek and destroy, and the antibodies that have found their way into the news cycle, another type of cell may be key: memory T cells.

T cells have numerous functions, including helping other immune cells develop into virus fighters. Studies have already shown that people who were never infected by SARS-CoV-2 have memory T cells that respond to the virus.

That suggests that memory T cells who are veterans of skirmishes with one of the four coronaviruses that cause the common cold may stick around for a while and can recognize SARS-CoV-2, perhaps even assisting in repelling the invader, a phenomenon known as cross-immunity. 

This may account for the wide array of severity in COVID-19 cases, as well as the high share of asymptomatic cases; plenty of people are afflicted by the common cold each year. Already-primed T cells could lead to a mild case — or potentially pique the immune system into overreaction and a cytokine storm.

The La Jolla team found that these memory T cells respond to specific protein sequences in SARS-CoV-2. Similar protein sequences were then identified in the more benevolent coronaviruses, proteins that activated the same memory T cells that appear to fight the new coronavirus. 

Catch a Cold to Combat Covid? 

Evidence for cross-immunity in coronaviruses is pretty sparse, Stephen Kissler, a postdoc researcher of immunology and infectious disease at the University of Cambridge, writes in The Conversation.

Figuring out if common cold coronaviruses help prime our immune system to protect us from COVID-19 is difficult, partially because we just plain don't keep good tabs on them. 

Studies have shown that people who were never infected by SARS-CoV-2 have memory T cells that respond to the virus.

Ideally, Kissler writes, researchers would have reams of historical data showing us where common cold coronavirus outbreaks have occurred, which can then be studied to see if there's a connection to their COVID-19 rates.

Kissler's got an idea to help us figure it out, however: a human challenge trial, like the kind being proposed to accelerate coronavirus vaccine development. Subjects would be purposefully infected with a mild coronavirus, then infected with SARS-CoV-2 to see how the immune system holds up.

As you can imagine, this leads to a real briar patch of ethical issues, and would be potentially risky — especially considering we have no current weapon against SARS-CoV-2 that can simply halt the disease in its tracks if things go south (although there are now promising treatments that help in some cases).

We'd love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Up Next

If you want to understand a problem, talk to the people working on solutions. Join us as we meet the people and explore the ideas on the frontlines of an unprecedented global response.

Coronavirus
Antivenom Scientists Are Using Horse Antibodies for COVID-19
horse antibodies for covid 19
Coronavirus
Antivenom Scientists Are Using Horse Antibodies for COVID-19
In Costa Rica, horse antibodies for COVID-19 are about to enter human trials.

In Costa Rica, horse antibodies for COVID-19 are about to enter human trials.

Coronavirus
Immune Signals May Predict Severe Cases of COVID-19
severe cases of covid-19
Coronavirus
Immune Signals May Predict Severe Cases of COVID-19
Severe cases of COVID-19 involve a runaway immune response called a cytokine storm. Immune system “signatures” may sharpen doctor’s forecasts.

Severe cases of COVID-19 involve a runaway immune response called a cytokine storm. Immune system “signatures” may sharpen doctor’s forecasts.

Coronavirus
Pfizer’s COVID-19 Vaccine Produces More Antibodies Than the Disease Itself
Pfizer’s COVID-19 Vaccine
Coronavirus
Pfizer’s COVID-19 Vaccine Produces More Antibodies Than the Disease Itself
Early data shows Pfizer’s COVID-19 vaccine produces immunity as good as, or better than, recovery from the virus.

Early data shows Pfizer’s COVID-19 vaccine produces immunity as good as, or better than, recovery from the virus.

Public Health
Fully See-Through Face Mask Ready for Mass Production
See-Through Face Mask
Public Health
Fully See-Through Face Mask Ready for Mass Production
The HelloMask is a fully see-through face mask made of a breathable material that offers the same protection as a standard surgical mask.

The HelloMask is a fully see-through face mask made of a breathable material that offers the same protection as a standard surgical mask.

Public Health
Where Did the Coronavirus Come From?
Where Did the Coronavirus Come From
Public Health
Where Did the Coronavirus Come From?
After analyzing dozens of coronaviruses, U.S. scientists believe COVID-19's origin story involves not one, but two animal species.

After analyzing dozens of coronaviruses, U.S. scientists believe COVID-19's origin story involves not one, but two animal species.

Public Health
Why Is an Antigen Test a Big Deal for COVID-19?
Antigen Test
Public Health
Why Is an Antigen Test a Big Deal for COVID-19?
The FDA has issued its first emergency use authorization for a COVID-19 antigen test, a new type of test for diagnosing the coronavirus.

The FDA has issued its first emergency use authorization for a COVID-19 antigen test, a new type of test for diagnosing the coronavirus.

Public Health
Lab Plans to Ship 20 Million Coronavirus Antibody Tests Per Month
Coronavirus Antibody Tests
Public Health
Lab Plans to Ship 20 Million Coronavirus Antibody Tests Per Month
Abbott Laboratories is shipping millions of coronavirus antibody tests to hospitals and labs across the United States.

Abbott Laboratories is shipping millions of coronavirus antibody tests to hospitals and labs across the United States.

Public Health
Major Drugmakers Team Up on Potential Coronavirus Vaccine
Potential Coronavirus Vaccine
Public Health
Major Drugmakers Team Up on Potential Coronavirus Vaccine
Major vaccine developers GlaxoSmithKline and Sanofi are collaborating on a potential coronavirus vaccine to help end the COVID-19 pandemic.

Major vaccine developers GlaxoSmithKline and Sanofi are collaborating on a potential coronavirus vaccine to help end the COVID-19 pandemic.

Public Health
New Study Boosts Case for At-Home Coronavirus Tests
at-home coronavirus tests
Public Health
New Study Boosts Case for At-Home Coronavirus Tests
A new study eliminates one major argument against at-home coronavirus tests: that patients won’t be able to collect usable samples themselves.

A new study eliminates one major argument against at-home coronavirus tests: that patients won’t be able to collect usable samples themselves.